ABOUT US
Swiss Alpha Matrix is guided by a team of former Managing Directors and senior executives from Tier-1 global banks, bringing decades of transactional, regulatory, and risk management expertise to every engagement.
We merge financial discipline, commercial precision, and Swiss discretion to deliver audit-grade due diligence, instrument validation, and program oversight that withstand institutional scrutiny.
Evidence-based recommendations
Clear, data-driven guidance that accelerates strategic decisions and streamlines execution across cross-border deals.
Protect capital & de-risk execution
Clear, data-driven roadmaps that accelerate strategic choices, safeguard capital and streamline complex execution.
Compliance-first partnerships
Partnering with sponsors, lenders and counsel to deliver bankable, measurable outcomes.
Our team is steered by a senior bench of former Managing Directors, Chief Risk Officers, and Programme Heads drawn from Tier-1 global institutions. Each partner brings decades of transactional leadership spanning structured finance, sovereign advisory, and capital-market operations.
DAVID SINGH
Chief Executive Officer
David Singh has a long and distinguished career in finance and banking spanning more than three decades, with a focus on Wealth Management and Investment Banking.
David established the Swiss Alpha Group in Switzerland in 1999, and the Group has expanded it’s services and operations across several countries, most recenlty in the USA where the Company operates an ‘SEC Registered Fund’ and has secured a ‘Money Service Business License’ authorised and regulated by FINCEN (The Financial Crimes & Enforcement Network, USA) which is a divsion of the United States Treasury Department.
With over 20 years Wealth Management & Advisory experience with family offices, David oversees a susbtantial portolfio of assets from some of the world’s premier families and UHNWI based mainly in Asia and the Middle East. David has deep relationships, developed over decades, and whereby David provides bespoke asset management and structured solutions to generate revenues and mitigate risk.
During his Investment Banking career, David gained over 9 years of multi-asset class Trading experience during which time David was a Proprietary and Structured Derivatives Trader, covering all asset classes, including: Derivatives (Equities, Fixed Income, FX etc); Commodities and ‘physical settlement / delivery’ mechanisms (Oil & Gas; LME, Precious Metals); Private Equity. As an investor in his own right, David has in depth experience of Private Equity, and Capital Markets (Debt & Equity) where he has an extensive network of Funding sources, both Institutional and Family Office.
David spent 2.5 years as an Independent advisor at Board level to Credit Suisse Group (2005) & Depfa Bank (2007), whereby he lead Projects on behalf of the Executive Management & Board (Reporting to Group CEO & Chairman).
In 2007, David lead the restructuring and subsequent sale of a listed European Bank for €5.7Bn: his largest M&A deal to date.
In addition to the above, and for more than a decade, David has been the CEO of the Family Office for a prominent Abu Dhabi Royal Family. David has developed a robust and elite network of investors and financial institutions across the GCC and Asia.
David’s last position in banking was as Managing Director of Julius Baer (Switzerland’s second largest bank)
DALIL GORDEEV
Managing Director, Project Management
Dalil Gordeev, is an international business development manager. He has launched and raised a number of retail and trading firms where he was CEO and Vice-Chairman.
Dalil has more than 10 years of work experience with healthcare and medical service organisations including MIPT research University where he held a position of project manager for Life science center. As an independent consultant he advised on developing and implementing innovating approach in the biopharmaceutical companies facilitating registration, production and market introduction of the new medications and healing meathods. Thus made a great contribution especially for patients with life-impacting diseases.
Since 2017 Dalil has held a position as a CEO of marketing and advertisement company. Using his knowledge and experienced business methods a company became a reliable partner for a Ministry of Atomic energy of Russia, Ministry of Sports of Russia, Ministry of Healthcare of Russia and a number of privately owned businesses.